Sunovion Pharmaceuticals Europe Announce the European Marketing Authorisation for Latuda ® ▼ (lurasidone) - a New Atypical Antipsychotic Medication for Adults with Schizophrenia
Year: 2014
Type: article
Author: Andrea Hall
Language: English
Subfield: Psychiatry and Mental health
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2551414105
